WEREWOLF THERAPEUTICS, INC. Increase (Decrease) in Contract with Customer, Liability
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2025-12-31, per its S-4 filed 2026-09-22.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-09-22
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $0.00.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $0.00.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was $0.00.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was $0.00.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was -$6.32M, a 182.51% decline from fiscal 2022.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was $7.66M.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | $0.00 derived: sum of 2 quarters · filed 2026-09-22 | $0.00 derived: sum of 3 quarters · filed 2026-09-22 | $0.00 S-4 · filed 2026-09-22 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-09-22 | $0.00 derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-09-22 | $0.00 derived: sum of 3 quarters · filed 2026-09-22 | -$933.00K derived: sum of 4 quarters · filed 2026-09-22 |
| 2024-12-31 | $0.00 derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | $0.00 derived: sum of 2 quarters · filed 2026-09-22 | -$933.00K derived: sum of 3 quarters · filed 2026-09-22 | -$1.34M S-4 · filed 2026-09-22 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$933.00K derived: sum of 2 quarters · filed 2025-11-04 | -$1.34M 10-Q · filed 2025-11-04 | -$2.40M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$933.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.34M 10-Q · filed 2025-08-14 | -$2.40M derived: sum of 3 quarters · filed 2025-08-14 | -$2.39M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$407.00K 10-Q · filed 2025-05-08 | -$1.47M derived: sum of 2 quarters · filed 2025-05-08 | -$1.46M derived: sum of 3 quarters · filed 2025-05-08 | -$4.38M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$1.05M derived: sum of 2 quarters · filed 2025-03-11 | -$3.98M derived: sum of 3 quarters · filed 2025-03-11 | -$6.32M 10-K · filed 2025-03-11 |
| 2023-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.92M derived: sum of 2 quarters · filed 2024-11-07 | -$5.26M 10-Q · filed 2024-11-07 | -$8.40M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$5.27M 10-Q · filed 2024-08-08 | -$8.41M derived: sum of 3 quarters · filed 2024-08-08 | -$10.68M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$2.34M 10-Q · filed 2024-05-03 | -$5.48M derived: sum of 2 quarters · filed 2024-05-03 | -$7.75M derived: sum of 3 quarters · filed 2024-05-03 | $5.32M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$5.41M derived: sum of 2 quarters · filed 2024-03-07 | $7.66M derived: sum of 3 quarters · filed 2024-03-07 | $7.66M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $10.80M derived: sum of 2 quarters · filed 2023-11-14 | $10.80M 10-Q · filed 2023-11-14 | $10.80M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $13.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $13.07M 10-Q · filed 2023-08-10 | $13.07M derived: sum of 3 quarters · filed 2023-08-10 | $13.07M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $0.00 derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 10-K · filed 2023-03-23 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |